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1. Introduction 
Supernatants from cultures of histo-incompatible 
spleen cells or spleen cells cultured in the presence of 
certain protein antigens or mitogens contain factors 
able to replace T cells during in vitro antibody syn- 
thesis [ 1,2]. Some of these show antigen specificity 
in their help, others are antigen-nonspecific. The name 
‘interleukin’ was suggested [3] for the antigen-non- 
specific factors. However, since these, in our studies, 
are biochemically very similar to an antigen-specific 
factor, we have used the same term for both groups 
of helper factors. Interleukin-I [3] has aMr of 
12 000-18 000 and appears to be produced mainly 
by macrophages [4]. Interleukin-2 [3] is produced 
by T cells, has a Mr of 30 000-35 000 and is, in 
addition to its T cell-replacing activity, able to pro- 
mote and maintain long-term cultures of T cells [3]. 
The biological and biochemical properties of the 
factors have been studied in several different labora- 
tories, but their structural characterization have 
encountered great difficulties, partly due to the very 
small amounts ofhelper factor present in supernatants 
having high levels of biological activity, and partly 
due to the apparent molecular heterogeneity of the 
helper factors [ 11. 
We have studied the heterogeneity of two differ- 
ently induced helper factors. One was antigen-specific 
in its action and was induced with the protein antigen 
Abbreviations: app. M,, apparent relative molecular mass; 
Con A, concanavalin A; DNP, 2,4dinitrophenol; HPLC, high 
pressure liquid chromatography; KLH, keyhole limpet hemo- 
cyanin 
* Present address: Dept. of Surgery, Edinburgh University 
Medical School, Teviot Place, Edinburgh, Scotland 
Elsevier/North-Holland Biomedical l+ess 
KLH, while the other one was antigen-nonspecific and 
induced with Con A. A series of conventional isola- 
tion procedures, such as ammonium sulfate precipita- 
tion, gel filtration and ion-exchange chromatography 
were employed to partially purify the factors. They 
were then further puriBed by reverse-phase HPLC and 
their app. Afr values determined by gel permeation 
HPLC in the presence of 6 M guanidine-HCl. It was 
found that even under denaturing conditions, it was 
not possible to obtain homogeneous factors. Biological 
activity was associated with material havingMr 
-2000-60 000. 
2. Materials and methods 
For the production of Con A factor, spleen cells 
from C57B1/6 mice were cultured (5 X lo6 cells/ml) 
in the presence of Con A (1 pg/ml) in serum-free 
Iscove’s modified Dulbecco’s medium (IMDM, Gibco 
[S]). Penicillin (100 units/ml), streptomycin (100 Irg/ 
ml), Lglutamine (2 mM) and 2-mercaptoethanol(5 X 
10” M) were added to the medium. After 24 h incu- 
bation, cells and cell-debris were removed by centrif- 
ugation and the supernatants were ammonium sulfate- 
precipitated (80% saturation). This material was fur- 
ther purified by gel filtration on Sephacryl S-200. 
The peak of biologically active factor was either anal- 
yzed directly by reverse phase HPLC (fig.1 A) or fur- 
ther purified by ion-exchange chromatography 
(DEAE-cellulose) and gel filtration (polyacrylamide 
P60) before analysis by HPLC (fig.1 B). 
The KLH-specific helper factor was also produced 
from culture supernatant of C57B1/6 spleen cells, but 
in the absence of Con A and in the presence of KLH 
(0.1 pg/ml) (details in [6]). The helper factor was 
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purified by ammonium sulfate precipitation, ion- 
exchange chromatography, gel filtration and HPLC 
(fig.lC). The puri~cation procedures for both factors 
have been described in detail (submitted). 
HPLC [7] was done using RP8 or RP18 reverse 
phase columns packed with LiChrosorb (Brownlee 
Labs.). The HPLC gel permeation column was the 
I-125 protein column of Waters Associates. 
The Con A factor activity was measured in a T celi 
replacing assay (stimulation of anti-sheep red blood 
cell antibody formation in cultures of nude spleen 
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cells [8] and in a thymocyte proliferation assay (stim- 
ulation of thymidine incorporation by thymocytes 
191). The KLH-specific factor activity was measured 
in an in vitro antibody response assay in which spleen 
ceils were incubated in the presence of DNI-KLH 
and the factor preparation to be assayed. After 4 days 
the number of plaque-forming cells were determined 
PA. 
3. Results 
In fig.1 are shown the HPLC elution profiles of the 
Con A-induced factor activity and the KLH-specific 
helper activity. The factor-conta~~g samples were 
injected into reverse phase columns in 12 mM HCl 
and eluted with linear gradients of ethanol in the same 
acid. The approximate thanol concentration which 
will elute a certain factor activity can be read on the 
abscissa. (A) and (B) both illustrate lution of Con A 
factor activity, but the factor material had been dif- 
ferently pre-treated in the two cases. After gel filtra- 
tion on Sephacryl S-200 columns (see section 2) the 
peak of factor-activity was in one case (A) charged 
directly onto the reverse-phase HPLC column, but 
in another case (B) it was taken through additional 
steps of puri~cation before analysis by HPLC. Appar- 
Fig. 1. Reverse-phase HPLC of partially purified interleukins. 
The helper factors were partially purified as in section 2, 
injected into reverse-phase HPLC columns in 12 mM HCI and 
eluted with linear gradients of ethanol in the same acid. Frac- 
tions of 200-300 ~1 were collected and, after removal of 
aliquots for assays, dried in vacuum and stored in liquid 
nitrogen. The Con A factor was assayed by its T cell-replacing 
activity, and the KLH-factor by its KLH-specific helper activ- 
ity. In the figure the activities are plotted as a function of the 
eluting ethanol concentration. (A) Con A factor prepurified 
by ammo~um sulfate pre~pitation and gel filtration (Sep- 
hacryl S-200). The insert shows the nlr, distribution, in the 
presence of 6 M guanidine-HCl, of the biologically active 
factor. The procedure is described in the text. The M, stan- 
dards were: ovalbumin, 46 000; myoglobin, 17 000; &endor- 
phin, 3900. (B) Con A factor pre-purified as in (A) followed 
by ion-exchange chromatography (DEAE-cellulose) and gel 
filtration (polyacrylamide P60). K,, = (Fe - V,)/(Vt - Vo) 
where V, = the volume of solvent required to elute the mole- 
cule of interest, Vt = the total column volume and PO = the 
void volume. (C) KLH-specific factor pre-purified as the Con A 
factor in (B) but without the fust gel filtration step (Sepha- 
cry1 S-200). The insert shows the &fr distrbution of the active 
factor, determined as in the text. The smallest A$ standard 
was insulin A chain at 2500. 
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ently the Con A factor taken through the short route 
of purification was considerably more hydrophobic 
(A) than the one pre-purified more extensively (B). 
Ethanol at 5540% was required to release the factor 
activity from the column in panel A, but only lo-25% 
ethanol eluted several peaks of activity in (B). Only 
the assay of T cell-replacing activity is shown in the 
figure, but the thymocyte growth-stimulating activity 
pattern was identical to this. 
In fig.l(C) is shown the elution profile of the KLH- 
specific factor. This material had been pre-treated in 
the same way as the Con A factor in (B) but without 
the gel filtration on Sephacryl S-200. The activity 
eluted in a narrow, but apparently not homogeneous 
peak at 25-30% ethanol, significantly later than the 
Con A factor in (B). In this connection it is of interest 
to mention that during ion-exchange chromatography 
of the two factors shown in (B) and (C), the KLH- 
specific factor was eluted from a DEAE-cellulose 
column at a lower ionic strength than that which 
eluted the Con A factor (not shown). This observa- 
tion, considered together with the elution patterns 
shown in fig.l(B) and l(C) could suggest that the 
KLH-specific factor is more hydrophobic than is the 
early-eluting (fig.l(B)) Con A factor. 
The heterogeneity of the Con A factor and the 
KLH-specific factor was further analyzed by deter- 
mining the app. Mr values of the two factors under 
native as well as under denaturing conditions in 6 M 
guanidine-HCl. Under native conditions the average 
app. M, of the factor material in all 3 panels of fig.1 
was -30 000-35 000 (determined by gel filtration 
on calibrated columns of Sephacryl S-200 and poly- 
acrylamide P60). A result which is in good agreement 
with values obtained in [l]. However, quite different 
results were obtained under denaturing conditions. 
Aliquots of the material shown in (A) and (C)were 
incubated for 30 min in 0.05 M Tris-HCl (pH 7.3); 
6 M guanidine-HCl at room temperature and then 
injected, together with MI standards, into a gel per- 
meation column (I-l 25 protein column, Waters Asso- 
ciates). Fractionation was done by HPLC using the 
same buffer as above. Pools were prepared’of fractions 
representing different Mr regions, and these were 
reinjected into the reverse phase BP1 8 column to 
remove the guanidine. Both factors were eluted with 
linear gradients of ethanol, 60-90’7% for the Con A 
factor, 25-65% for the KLH factor, and their respec- 
tive activities were assayed. The inserts in fig.l(A) 
and l(C) show the size distributions of the biologi- 
tally active factors. ~~0~~ they both had approxi- 
mately the same Mr under native conditions, it is 
apparent that 6 M guanidine was able to separate 
several differently sized factor components from each 
other. In both cases, active material having a Mr of 
only 1500-3000 was seen. The highest MI observed 
for active Con A factor was -60 000 (A), but only 
-20 000-30 000 for the KLH factor (C). The MI was 
not determined for the Con A factor material (fig. l(B)) 
taken through the same steps of purification as the 
KLH factor, but based on their similar biochemic~ 
behavior and elution positions after HPLC, it is 
expected that also that factor activity will contain a 
mixture of high and low M, material. The KLH factor 
purified through the HPLC step had retained its anti- 
gen specificity. Fig.2 shows that a significant antibody 
response was obtained only when DNP was bound to 
the appropriate carrier, KLH. It is presently not clear 
how such a small component can retain antigen spe- 
cificity. It is the hope that further biological and bio- 
chemical studies on purified KLH factor will clarify 
this problem. 
4. Discussion 
It appears that the app. MI values are not reliable 
characteristics of the mouse interleukins. Biologically 
active, extensively purified factors with native M, of 
-30 000-35 000 could under denaturing conditions 
Fig.2. Carrier specificity of KLH factor. The specificity of 
the KLH-induced helper factor was evaluated in an in vitro 
assay in which the anti-DNP antibody response was measured 
when DNP was bound to the different carriers listed. 
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in acid and in 6M guanidine have &fr of 2000-60 000. 
Therefore, it should be expected that one factor will 
be able to appear in different 1M, forms, depending on 
its en~ronm~t. In fact, helper factors of different 
sizes have been reported [10,l I], and it was suggested 
[12] that their app. Mr values were dependent on the 
factor concentration. 
The heterogeneity of the two interleukins tudied 
was most likely caused by a combination of covalent 
and noncovalent interactions between components of 
small Mr. The nature of the covalentbonds i  not 
known, but since preliminary evidence suggests he 
presence of cysteine in the Con A factor, small Mr 
material could possibly be covalently ‘aggregated’ by
formation of disul~de bridges. Further studies in 
which this possibility will be investigated are currently 
in progress. 
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